Dr. Ravi Kiron
Dr. Ravi Kiron is well versed in various aspects of the pharma and biotech R&D value chain across from early discovery, pre-clinical through late-stage clinical development, IP & regulatory strategy, corporate, product, technology & business development, marketing & launch – for well over 30 years.
He has held consulting operational business roles at various biotech’s (e.g. Aduro, Kinemed, Amarantus, Clasado), cofounded companies (C2N Diagnostics, Navya Biomedical Technologies, iRetainRx), was an EIR (Entrepreneur/Executive in Residence) at SRI International and ShangPharma Innovation. He consulted for many (>50clients/10years) global pharma, biotech’s, diagnostics, CRO’s, Private Equity, Hedge Funds and Universities for M&A due diligence, market assessment, valuation, fund-raising through global VC’s, HNWI, Foundations, BD and in/out licensing.
Dr. Kiron gained experiences at large pharma (Pfizer and J&J/ALZA) in various scientific, business, executive roles – Cardiovascular Drug Discovery, Oncology Drug Development, Business Development, Strategic Alliances, Project & Alliance Management, Drug Delivery Licensing and IP management. At Pfizer, he was primary architect of many global partnerships, was an acquisition/integration team member for Pfizer’s purchase of Warner Lambert ($95B) Pharmacia ($65B), and other biotech companies. Dr. Kiron was also exploratory drug development project champion at Pfizer resulting in IND filing of Tarceva® for the treatment of NSCLC and filed an IND for Clasado of a novel prebiotic to prevent Travelers Diarrhea – leveraging the human microbiome.
Earlier in academia, Dr. Kiron was a tenure-track Assistant Professor of Biochemistry & Medicine faculty (joint appointments) at Cornell University Medical Center (NY Hospital), New York and had an Adjunct appointment at University of Rhode Island, Kingston, RI, USA. He serves on non-profit BOD’s.
He holds BSc in Chemistry, MSc in Microbiology through colleges in Goa, India, under Bombay University, earned PhD in Biochemistry from the Indian Institute of Science, Bangalore, India and an MBA in Entrepreneurship from Rensselaer, New York, USA.